The Beijing Internet Court has issued a compelling call for intensified regulatory supervision within China’s rapidly expanding online food and pharmaceutical sectors. Vice-President Yi Jun emphasized the critical intersection of digital commerce and consumer safety during a recent address, highlighting both the tremendous growth and emerging challenges in these vital industries.
Statistical projections reveal remarkable expansion in China’s food e-commerce market, with transaction volumes anticipated to surge from 2.4 trillion yuan ($328 billion) in 2023 to an estimated 3.3 trillion yuan by 2025. This digital transformation has fundamentally altered consumption patterns, making online platforms primary distribution channels for food and pharmaceutical products.
However, this exponential growth has been accompanied by significant consumer protection concerns. Judicial data from 2023 to 2025 documents 2,061 cases related to online food and drug consumption, exposing pervasive issues including deceptive marketing practices, unauthorized sales operations, and counterfeit merchandise. Particularly alarming are instances of manufacturers improperly utilizing additives and prohibited substances to maximize profits, coupled with inadequate verification processes by digital marketplaces regarding seller credentials.
The court has responded by enhancing judicial scrutiny of such cases, implementing punitive damages in severe violations to safeguard consumer interests. Approximately 65% of adjudicated cases resulted in full or partial support for consumer claims, with nearly 40% culminating in financial penalties against negligent sellers or producers.
Judicial recommendations include mandatory accurate labeling information disclosure to ensure consumer awareness, strengthened oversight of merchant qualifications on digital platforms, and simplified reporting mechanisms for problematic products. The court further advocates immediate removal of violative items and store suspensions upon violation detection, alongside mandatory reporting to regulatory authorities.